Asymchem offers a broad range of cost effective Process R&D services including route development, optimization and manufacture of clinical and commercial quantities of pharmaceutical intermediates and API's. Asymchem maintains USFDA inspected facilities in China for cGMP production from kg to multiton levels.
Asymchem's expertise lies in developing economically and safely feasible routes for scaleup of technically complex API's, with the added advantage of in-house raw materials manufacturing to control availability and lead-times. From the initiation of a project, the development of synthetic process through to manufacturing is supported by our scale-up team, meeting full GMP compliance and regulatory requirements. For projects at late phase of development, Asymchem's commercial team can handle Technical Transfers of existing process into our manufacturing facilities.
Asymchem's offerings include Continuous Reactions Technologies, Asymmetric Synthesis, High Potency/Cytotoxics, Low Temperature reactions, Catalytic Hydrogenations, and many others.